INGALLS & SNYDER LLC – ImmunoPrecise Antibodies Ltd. Transaction History
INGALLS & SNYDER LLC portfolio value:
$3.85M
portfolio value
INGALLS & SNYDER LLC quarter portfolio value change:
+5.00%
quarter
ImmunoPrecise Antibodies Ltd. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.94% | 27.61K shares | 289K | $3.99 | 967.09K |
| Q2 2022 | share | Increase | +0.78% | 7.27K shares | -1.22M | $3.8 | 939.47K |
| Q1 2022 | share | Increase | +13.65% | 111.94K shares | 395K | $5.14 | 932.2K |
| Q4 2021 | share | Increase | +31.99% | 198.81K shares | 532K | $5.45 | 820.25K |
| Q3 2021 | share | Increase | +3.43% | 20.63K shares | 248K | $6.22 | 621.44K |
| Q2 2021 | share | Increase | +16.17% | 83.61K shares | -1.46M | $6.02 | 600.81K |
| Q1 2021 | share | Increase | +30.46% | 120.77K shares | -848K | $9.82 | 517.19K |
| Q4 2020 | share | Increase | 0.00% | 396.42K shares | 5.92M | $14.95 | 396.42K |